伐尼克兰治疗后出现的撤药后运动障碍
Withdrawal-Emergent Dyskinesias following Varenicline Therapy.
作者信息
Toffey Brittany A, Rabin Marcie, Kurlan Roger
机构信息
Atlantic Neuroscience Institute, Overlook Medical Center, 99 Beauvoir Avenue, Summit, NJ 07901, USA.
出版信息
Open Neurol J. 2015 May 29;9:7-8. doi: 10.2174/1874205X01509010007. eCollection 2015.
Abstract
Varenicline (Chantix[R]) is a nicotinic acetylcholine receptor partial agonist used to aid smoking cessation. Adverse psychiatric and behavioral effects of the drug are recognized and national drug monitoring has included reports of tardive dyskinesia, but no cases have been described in the literature. We now report the first two cases of varenicline-related withdrawal emergent dyskinesias.
摘要
伐尼克兰（畅沛[R]）是一种用于辅助戒烟的烟碱型乙酰胆碱受体部分激动剂。该药物的不良精神和行为影响已得到认可，国家药物监测已包括迟发性运动障碍的报告，但文献中尚未描述过相关病例。我们现在报告首例两例与伐尼克兰相关的戒断后突发运动障碍病例。
相似文献
1
Withdrawal-Emergent Dyskinesias following Varenicline Therapy.
Open Neurol J. 2015 May 29;9:7-8. doi: 10.2174/1874205X01509010007. eCollection 2015.
2
Effect of Varenicline on Tardive Dyskinesia: A Pilot Study.
Clin Psychopharmacol Neurosci. 2021 May 31;19(2):355-360. doi: 10.9758/cpn.2021.19.2.355.
3
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2011 Feb 16(2):CD006103. doi: 10.1002/14651858.CD006103.pub5.
4
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2010 Dec 8(12):CD006103. doi: 10.1002/14651858.CD006103.pub4.
5
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2008 Jul 16(3):CD006103. doi: 10.1002/14651858.CD006103.pub3.
6
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.
7
Varenicline: a review of its use as an aid to smoking cessation therapy.
CNS Drugs. 2006;20(11):945-60. doi: 10.2165/00023210-200620110-00007.
8
Varenicline: progress in smoking cessation treatment.
Expert Opin Pharmacother. 2007 Aug;8(11):1757-67. doi: 10.1517/14656566.8.11.1757.
9
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
JAMA. 2006 Jul 5;296(1):56-63. doi: 10.1001/jama.296.1.56.
10
Taking varenicline for smoking cessation: A rare cause of pulmonary thromboembolism with infarction.
Am J Emerg Med. 2017 Jul;35(7):1037.e3-1037.e6. doi: 10.1016/j.ajem.2017.02.044. Epub 2017 Feb 28.
引用本文的文献
1
Effect of Varenicline on Tardive Dyskinesia: A Pilot Study.
Clin Psychopharmacol Neurosci. 2021 May 31;19(2):355-360. doi: 10.9758/cpn.2021.19.2.355.
2
Possible varenicline withdrawal-induced akathisia: A case report.
Ment Health Clin. 2019 Sep 4;9(5):322-325. doi: 10.9740/mhc.2019.09.322. eCollection 2019 Sep.
本文引用的文献
1
Quitting smoking without a psychotic break: the potential link between nicotinic acetylcholine receptor partial agonists and neuropsychiatric adverse events.
Clin Nurse Spec. 2009 Jan-Feb;23(1):13-5. doi: 10.1097/01.NUR.0000343072.42590.43.
2
Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial.
Eur Psychiatry. 2009 Jan;24(1):33-40. doi: 10.1016/j.eurpsy.2008.07.007. Epub 2008 Sep 6.
3
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
Neuropharmacology. 2007 Mar;52(3):985-94. doi: 10.1016/j.neuropharm.2006.10.016. Epub 2006 Dec 8.
4
Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs.
Am J Psychiatry. 1980 Oct;137(10):1163-72. doi: 10.1176/ajp.137.10.1163.
5
Nicotine exposure and tardive dyskinesia.
Biol Psychiatry. 1987 Jan;22(1):67-72. doi: 10.1016/0006-3223(87)90131-4.
Zotero 插件